Rare Disease Trial, Not Yet Recruiting NCT07714161 Sponsor: Mayo Clinic Condition: Rare Disease
Back to Rare Disease

Rare Disease Trial, Not Yet Recruiting

NCT07714161
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People of any age (including children) who are receiving or have previously received care at Mayo Clinic for a rare or undiagnosed condition, and who are able to give informed consent themselves or have a legally authorised representative who can do so on their behalf.
  • People who have already had standard genetic testing that did not provide a diagnosis, and whose case has been put forward by a Mayo Clinic clinician and selected by the study team.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who already have a confirmed genetic or clinical diagnosis that fully explains their symptoms and condition.
  • People who are unable to give consent themselves and do not have a legally authorised representative to consent on their behalf.
  • People whose medical samples cannot be collected and coordinated by the study team.
  • People who are currently enrolled in another clinical trial that does not allow participation in additional genetic research (each situation is assessed individually).
  • People who are currently in prison.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 18 August 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Eric Klee, Ph.D., Mayo Clinic

Phone: 507-738-7890

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
1 August 2026
Est. completion
1 August 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Feasibility of establishing a biospecimen and data repository

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 18 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov